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SUMMARY
Murine hepatitis virus strains A59 and JHM replicated with equal efficiency in both nucleated and enucleated L2 cells. In addition, treatment of the host cell with either actinomycin D or a-amanitin, both inhibitors of host cell RNA synthesis, had no effect on virus replication. Therefore, the replication of murine hepatitis virus did not appear to depend upon either the presence of the host cell nucleus or continued host cell RNA synthesis.
Murine hepatitis viruses (MHV) are members of the coronavirus group and contain single-stranded, polyadenylated RNA genomes (Lai & Stohlman, 1978; Wege et al., 1978) . Although intracellular MHV-specific mRNAs are detectable in cells treated with actinomycin D (Spaan et aL, 1981; Lai et aL, 1981) , nuclear virus antigen has been reported (Robb & Bond, 1979) . In addition, Kennedy & Johnson-Lussenburg (1979) have shown that the synthesis of human coronavirus strain 229E infectious particles is inhibited in the presence of actinomycin D. The prototypic coronavirus, avian infectious bronchitis virus (IBV) (Tyrrell et al., 1978) , does not replicate in enucleated cells or in the presence of a-amanitin, although IBV-specific RNA is synthesized in the presence of actinomycin D (Evans & Simpson, 1980) . In this communication, we report that MHV replication is independent of host cell nuclear functions.
L2 cells obtained through the courtesy of Dr L. S. Sturman (New York State Department of Health, Albany, N.Y., U.S.A.) were enucleated by centrifugation in the presence of cytochalasin B (Prescott et al., 1972) . Briefly, 12 mm glass coverslips were sulphonated by soaking in 18 M-H2SO 4 for 30 min and then rinsed in running tap water for 15 rain. To enhance cellular adherence (Mazia et al., 1975) sterilized coverslips were coated with poly-L-lysine (Sigma) by incubation for 2 h at 37 °C in Dulbecco's modified minimum essential medium (DMEM) containing 2% newborn calf serum (NBCS) and 0.1% poly-L-lysine. Following incubation, the coverslips were washed once with sterile distilled water and twice with DMEM containing 2% NBCS before addition of the L2 cells. L2 cells were seeded on to the coverslips and were allowed to attach for 24 h before use. Coverslips were placed cell side down in 15 ml centrifuge tubes containing 5 ml DMEM containing 2% NBCS and 10 gg/ml cytochalasin B (Sigma), and were centrifuged in a JA-20 rotor at 12000 rev/min for 15 min at 35 °C. The cells were rinsed once in DMEM containing 2% NBCS and then were incubated at 37 °C for 30 min in DMEM containing 2% NBCS before use. Enucleation of each preparation was determined by counting the number of nucleated cells in a total of 300 cells. The percentage of enucleated cells averaged > 95 % and approx. 85 % of the starting cell population was retained following the enucleation procedure.
MHV strains A59 (MHV-A59), JHM (MHV-JHM) and the Indiana strain of vesicular stomatitis virus (VSV) were grown in L2 cells and plaque-assayed on DBT cells using DMEM containing 0.5% foetal bovine serum, with 0.6% agarose in the overlay as described previously (Stohlman & Weiner, 1978) . Coverslips were infected with both MHV-A59 and MHV-JHM at an m.o.i, of approx. 10. Coverslips were infected with VSV at an m.o.i, of approx. 100. The mouse-adapted A/PR8/3/34 strain of influenza virus was obtained from Dr H. F. Maassab (The University of Michigan, Ann Arbor, Mi., U.S.A.); this was propagated by allantoic infection of 10-day-old embryonated hens' eggs and was plaque-assayed on monolayers of L2 cells as described above, except that serum was deleted from the overlay. Coverslips were infected with influenza virus at an m.o.i, of approx. 1. We first examined the synthesis of infectious MHV-A59, virus antigen and virus-specific RNA synthesis in cells treated with actinomycin D, a gift of Merck Sharp & Dohme (Rahway, N.J., U.S.A.). Virus-specific RNA synthesis in both L2 and DBT cells peaked at 7 to 9 h post-infection and was easily detectable under conditions which reduced host cell RNA synthesis >95% (Lai et al., 1981) . Virus antigen synthesis, determined by fluorescent antibody techniques (Stohlman & Weiner, 1978) , was not suppressed in actinomycin D-treated cells and was not detected in the nuclei of either DBT or L2 cells (data not shown). In addition, virus replication in L2 cells was unaffected by the presence of 3 /lg/ml actinomycin D in the growth medium (Table 1) . Similar results were obtained in DBT cells infected with MHV-A59 (Lai et al., 1981) .
To further examine the involvement of the host cell nucleus in MHV replication, enucleated, mock-enucleated (treated as the enucleated cells but not centrifuged) and tt-amanitin-treated cells were infected with MHV-A59, MHV-JHM, VSV and influenza virus. Table I shows that the replication of MHV-A59, MHV-JHM and VSV was not restricted in enucleated cells, in cells treated with ~-amanitin, or in cells treated with both ~-amanitin and actinomycin D. The moderate decrease in MHV-A59 replication in the enucleated cells was probably due to the disruption of cellular metabolism by cytochalasin B treatment, since a similar decrease was observed in mock-enucleated cells. Replication of VSV is known to be unaffected by these treatments; however, influenza virus replication is suppressed (Follett et al., 1974; Evans & Simpson, 1980) . The data obtained in this study indicate that the host cell nucleus is not required for the synthesis of MHV. Our results confirm and extend the recently reported results of Wilhelmsen et al. (1981) . They reported that MHV-A59 and MHV-JHM, both derived from the same parental virus strains used in this report, would replicate in enucleated 17 CL-1 cells. While Wilhelmsen et al. (1981) reported reduced titres of MHV in 17 CL-1 cytoplasts compared to mock-enucleated cells, electron photomicrographs clearly show the replication of typical coronavirus-like particles in these cytoplasts.
These data showing nuclear independence of MHV replication in L2 cells contrast with those obtained for coronavirus 229E in L132 cells and IBV in BHK-21 cells (Kennedy & Johnson-Lussenburg, 1979; Evans & Simpson, 1980) . Although Evans & Simpson (1980) report that actinomycin D and ~-amanitin blocked the production of IBV, Stern & Kennedy (1980) observed no reduction in the recovery of infectious IBV from chicken embryo kidney cells incubated in the presence of 1/tg/ml actinomycin D. Unfortunately, we cannot resolve the difference between our data with MHV and those of Evans & Simpson (1980) obtained with IBV, as neither BHK-21 nor CHO ceils will support the growth ofMHV (S.A. Stohlman, unpublished results). MHV differs from the prototype coronavirus IBV in a number of respects. For example, Davies & MacNaughton (1979) have reported that IBV has a greater diameter than MHV and that the virus surface projections are morphologically distinct. Also, MHV has a genome that is smaller than IBV (Lai & Stohlman, 1978; Wege et al., 1978; Spaan et al., 1981; Watkins et al., 1975; Lomniczi & Kennedy, 1977) . In addition, MHV has four or five structural proteins (Wege et al., 1979; Anderson et al., 1979; Bond et al., 1979; MacNaughton, 1980) , while IBV has six to sixteen structural proteins (Bingham, 1975; Alexander & Collins, 1977; MacNaughton & Madge, 1977; Nagy & Lomniczi, 1979) . The data presented here regarding MHV imply a basic difference in the replication cycles of IBV and MHV and add further evidence of molecular differences within the Coronaviridae.
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